Table of Content


Chapter 1   Methodology and Scope
1.1    Market scope and definitions
1.2    Research design
1.2.1    Research approach
1.2.2    Data collection methods
1.3    Base estimates and calculations
1.3.1    Base year calculation
1.3.2    Key trends for market estimation
1.4    Forecast model
1.5    Primary research and validation
1.5.1    Primary sources
1.5.2    Data mining sources
Chapter 2   Executive Summary
2.1    Industry 360? synopsis
Chapter 3   Industry Insights
3.1    Industry ecosystem analysis
3.2    Industry impact forces
3.2.1    Growth drivers
3.2.1.1    Rising prevalence of chronic pain and inflammatory diseases
3.2.1.2    Technological advancement in drug delivery systems
3.2.1.3    Awareness and accessibility of OTC NSAIDs
3.2.2    Industry pitfalls and challenges
3.2.2.1    Side effects and safety concerns
3.2.2.2    Stringent regulatory scenario
3.3    Growth potential analysis
3.4    Regulatory landscape
3.5    Gap analysis
3.6    Pipeline analysis
3.7    Porter’s analysis
3.8    PESTEL analysis
Chapter 4   Competitive Landscape, 2024
4.1    Introduction
4.2    Company market share analysis
4.3    Company matrix analysis
4.4    Competitive analysis of major market players
4.5    Competitive positioning matrix
4.6    Strategy dashboard
Chapter 5   Market Estimates and Forecast, By Drug Class, 2021 – 2034 ($ Mn)
5.1    Key trends
5.2    Selective COX-2 inhibitors
5.3    Non-selective COX inhibitors
Chapter 6   Market Estimates and Forecast, By Route of Administration, 2021 – 2034 ($ Mn)
6.1    Key trends
6.2    Oral
6.3    Parenteral
6.4    Topical
Chapter 7   Market Estimates and Forecast, By Application, 2021 – 2034 ($ Mn)
7.1    Key trends
7.2    Arthritis
7.3    Migraine
7.4    Ophthalmic diseases
7.5    Other applications
Chapter 8   Market Estimates and Forecast, By Distribution Channel, 2021 – 2034 ($ Mn)
8.1    Key trends
8.2    Hospital pharmacies
8.3    Retail pharmacies
8.4    Online pharmacies
Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2034 ($ Mn)
9.1    Key trends
9.2    North America
9.2.1    U.S.
9.2.2    Canada
9.3    Europe
9.3.1    Germany
9.3.2    UK
9.3.3    France
9.3.4    Spain
9.3.5    Italy
9.3.6    Netherlands
9.4    Asia Pacific
9.4.1    China
9.4.2    India
9.4.3    Japan
9.4.4    Australia
9.4.5    South Korea
9.5    Latin America
9.5.1    Brazil
9.5.2    Mexico
9.5.3    Argentina
9.6    Middle East and Africa
9.6.1    Saudi Arabia
9.6.2    South Africa
9.6.3    UAE
Chapter 10   Company Profiles
10.1    Abbott Laboratories
10.2    Bayer AG
10.3    Cipla
10.4    Dr. Reddy’s Laboratories
10.5    Glenmark Pharmaceuticals
10.6    Hikma Pharmaceuticals
10.7    Johnson & Johnson
10.8    Lupin
10.9    Novartis
10.10    Pfizer
10.11    Sun Pharmaceutical Industries
10.12    Teva Pharmaceuticals
10.13    Torrent Pharmaceuticals
10.14    Viatris
10.15    Zydus Healthcare